Liver disease risk may be heightened by gastric acid drugs

By EASL October 20,2017
Researchers found that proton pump inhibitors, which are drugs used to reduce gastric acid, could promote the growth of a type of bacteria associated with chronic liver diseases. Proton pump inhibitors (PPIs) are drugs that reduce the production of gastric, or stomach acid in the long-term. PPIs are often used to treat gastroesophageal reflux disease, which is a condition wherein gastric acid travels up to the esophagus, producing an uncomfortable burning sensation.
To read the full story, visit: MedicalNewsToday